Ackman's fund falls 7 percent in March, hurt by Valeant

BOSTON (Reuters) - Billionaire investor William Ackman's Pershing Square Holdings, Ltd fund lost 7.1 percent last month, hurt largely by Valeant Pharmaceuticals' (NYSE: VRX) roughly 60 percent tumble in March.

March's poor performance leaves Ackman's fund with a 25.6 percent loss for the year, a person familiar with its returns said on Friday. This marks a dramatic turnaround from Pershing Square's 40 percent gain in 2014.

Pershing Square owns a 9 percent stake in Valeant and the company's stock tumbled last month when it cut its financial forecasts and said it could face default if it fails to file its annual report by the end of April. Last week the company's chief executive officer agreed to step down and Ackman formally joined the board.

(Reporting by Svea Herbst-Bayliss; Editing by Chris Reese)

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Morning Bid: BOJ struggling to keep pace with hiking partners
• Moody's raises India fiscal 2027 GDP growth forecast to 7% on Middle East resilience
• Investors react to BOJ raising interest rates to 31-year high